Coya Therapeutics Inc
COYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$87.77M
Close$
$-0.74
116% downside
Current Fair Value
116% downsideOvervalued by 116% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $87.77 Million |
|---|---|
| Enterprise Value | $-49,394,241,815.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 0.55 |
| Outstanding Shares | 16,730,274 |
Return
| Return on Equity | -16.79% |
|---|---|
| Return on Assets | -15.44% |
| Return on Invested Capital | -17.18% |
Valuation & Multiples
| P/E Ratio | -3.82 |
|---|---|
| PEG | 279.55 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -13.84 |
| Enterprise Value to EBIT | 5.78 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | -0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
$150,000
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$156,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 63,400▲ Infinity% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.61%▲ 1.16% |
|---|---|
| Total Invested | $32.05M▼ 30.40% |
| Investors Holding | 580% |
ESG Score
No data